U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Vaccines, Blood & Biologics
  3. Safety & Availability (Biologics)
  4. Expiration Date Extension for 6 ASCENIV [Immune Globulin Intravenous, Human-slra, 10% Liquid] Lots manufactured in 2019 - 2020
  1. Safety & Availability (Biologics)

Expiration Date Extension for 6 ASCENIV [Immune Globulin Intravenous, Human-slra, 10% Liquid] Lots manufactured in 2019 - 2020

This is to provide you with important information regarding Immune Globulin Intravenous, Human-slra, 10% Liquid, referred to as ASCENIV™, which is indicated for the treatment of primary humoral immunodeficiency (PI).

ASCENIV is manufactured by ADMA Biologics. The FDA has approved an extension of the expiration date for ASCENIV from 24 to 36 months when stored at +2°C to +8°C (36°F to 46°F). The new expiration date is valid for 6 ASCENIV lots that were manufactured and distributed in 2019-2020. Future lots will be labeled according to the new dating period.

Please see the list of lots, below, to identify ASCENIV vials affected by the extended  dating period. The lot number is visible on vials and outer carton labels. You may continue to dispense product from the lots below when stored at 2-8oC, until the new expiration date.

Lot Labeled Expiration Date New Expiration Date
2618-20 SEP-22 SEP-23
2619-20 SEP-22 SEP-23
2618201 SEP-22 SEP-23
2817-21 SEP-23 SEP-24
229015 NOV-23 NOV-24
229156 DEC-23 DEC-24
Back to Top